Concepedia

Author

Shichang Miao

Amgen (United States)

Also Known As

Miao, Shichang, Shichang Miao

61

Publications

2.2K

Citations

26

H-Index

95

Concepts

All Affiliations

Amgen (United States)ChemoCentryx (United States)University of British Columbia
SM

About

Shichang Miao is an author at Amgen (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

26

1.2K

2

Natural Sciences

11

11

492

3

Engineering

5

5

274

4

Arts

1

1

13

5

Allergy

1

1

144

Shichang Miao

×

40

Publications

2.2K

Citations

26

H-Index

YearCitations

T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities

Gary Lee, Fabienne Elwood, John McNally,

Journal of Biological Chemistry

2002

319

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study

Pirow Bekker, Daniel J. Dairaghi, Lisa Seitz,

PLoS ONE

2016

144

Rubrolides A-H, metabolites of the colonial tunicate Ritterella rubra

Shichang Miao, Raymond J. Andersen

The Journal of Organic Chemistry

1991

126

Identification of Glutamic Acid 78 as the Active Site Nucleophile in Bacillus subtilis Xylanase Using Electrospray Tandem Mass Spectrometry

Shichang Miao, Lothar Ziser, Ruedi Aebersold,

Biochemistry

1994

106

Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3

Michael G. Johnson, An‐Rong Li, Jiwen Liu,

Bioorganic & Medicinal Chemistry Letters

2007

103

Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial

Paul P. Tak, Andra Bălănescu, Vira Tseluyko,

Annals of the Rheumatic Diseases

2012

98

Secondary metabolites of the aspen fungus <i>Stachybotrys</i> <i>cylindrospora</i>

William A. Ayer, Shichang Miao

Canadian Journal of Chemistry

1993

94

Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced/metastatic pancreatic cancer: Correlation with blood monocyte counts.

David C. Linehan, Marcus Smith Noel, Aram F. Hezel,

Journal of Clinical Oncology

2018

90

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Daniel J. Dairaghi, Babatunde O. Oyajobi, Anjana Gupta,

Blood

2012

86

C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study

Annette Bruchfeld, Patrick H. Nachman, Samir M. Parikh,

Clinical Kidney Journal

2021

84

Page 1